Insights

Strategic Partnerships Optellum’s recent collaborations with industry leaders such as Bristol-Myers Squibb, Volpara Health, and DKFZ demonstrate a strong push into integrated AI-driven lung cancer diagnostics, representing significant opportunities for technology and service expansion in clinical and pharmaceutical markets.

Innovative Technology Their advanced AI platform, combining machine learning with extensive clinical data, positions Optellum as a promising provider of personalized early detection solutions, appealing to hospitals and healthcare providers seeking cutting-edge diagnostic tools.

Funding & Growth With $14 million raised in Series A funding and a revenue range of $1 million to $10 million, Optellum shows growth potential, making it a compelling partner for investors and stakeholders interested in innovative medical AI startups focused on early cancer detection.

Market Differentiation Optellum’s focus on early lung cancer diagnosis and its strategic alliances with AI platforms like Eureka and TeraRecon indicate a binding ecosystem, offering integrated solutions that can be tailored for hospital systems and cancer centers seeking comprehensive AI-based diagnostic workflows.

Global Expansion With a team of top-tier experts from academia and technology firms and an international presence, Optellum is positioned to expand its reach into global markets, providing scalable AI solutions for oncology clinics worldwide and opening opportunities for sales channels and strategic alliances.

Optellum Tech Stack

Optellum uses 8 technology products and services including WP-Statistics, oEmbed, Twemoji, and more. Explore Optellum's tech stack below.

  • WP-Statistics
    Analytics
  • oEmbed
    Dev Tools
  • Twemoji
    Font Scripts
  • Angular
    Javascript Frameworks
  • Python
    Programming Languages
  • Yoast SEO
    Search Engines
  • Nginx
    Web Servers
  • Bokun
    Widgets

Media & News

Optellum's Email Address Formats

Optellum uses at least 1 format(s):
Optellum Email FormatsExamplePercentage
First.Last@optellum.comJohn.Doe@optellum.com
59%
Last.First@optellum.comDoe.John@optellum.com
32%
FirstLast@optellum.comJohnDoe@optellum.com
4%
FLast@optellum.comJDoe@optellum.com
5%

Frequently Asked Questions

Where is Optellum's headquarters located?

Minus sign iconPlus sign icon
Optellum's main headquarters is located at Oxford Centre for Innovation, Oxford, Oxfordshire OX11BY, GB. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Optellum's official website and social media links?

Minus sign iconPlus sign icon
Optellum's official website is optellum.com and has social profiles on LinkedInCrunchbase.

What is Optellum's NAICS code?

Minus sign iconPlus sign icon
Optellum's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Optellum have currently?

Minus sign iconPlus sign icon
As of October 2025, Optellum has approximately 50 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: J. W.Chief Product & Strategy Officer: V. P.Chief Operating Officer: T. P.. Explore Optellum's employee directory with LeadIQ.

What industry does Optellum belong to?

Minus sign iconPlus sign icon
Optellum operates in the Medical Equipment Manufacturing industry.

What technology does Optellum use?

Minus sign iconPlus sign icon
Optellum's tech stack includes WP-StatisticsoEmbedTwemojiAngularPythonYoast SEONginxBokun.

What is Optellum's email format?

Minus sign iconPlus sign icon
Optellum's email format typically follows the pattern of First.Last@optellum.com. Find more Optellum email formats with LeadIQ.

How much funding has Optellum raised to date?

Minus sign iconPlus sign icon
As of October 2025, Optellum has raised $14M in funding. The last funding round occurred on Sep 27, 2022 for $14M.

When was Optellum founded?

Minus sign iconPlus sign icon
Optellum was founded in 2016.

Optellum

Medical Equipment ManufacturingUnited Kingdom11-50 Employees

Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way.  

Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset. 

We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO.

We are backed by an Advisory Board comprising world-leading clinicians (global authors of medical guidelines) and experts in deep learning.  

We are building up our development team – join our fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups.

Learn more at http://www.optellum.com/.

Section iconCompany Overview

Headquarters
Oxford Centre for Innovation, Oxford, Oxfordshire OX11BY, GB
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $14M

    Optellum has raised a total of $14M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2022 in the amount of $14M.

  • $1M$10M

    Optellum's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $14M

    Optellum has raised a total of $14M of funding over 3 rounds. Their latest funding round was raised on Sep 27, 2022 in the amount of $14M.

  • $1M$10M

    Optellum's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.